My Account
J&J
SYMBOL:JNJ|SECTOR:Health Care|DERIVED:CFD
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices are indicative only and not appropriate for trading purposes. Therefore Moneycontrol doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
$58151
5
8
.
1
5
1
-1.45 (-0.95%)
As on 29 Mar, 2023 | 01:29 IST
Day Range
151.74
153.45
LH
52 Week Range
150.11
186.69
LH
| Open | 152.43 |
| Previous Close | 153.30 |
| Beta | 0.03 |
| High | 153.45 |
| Low | 151.74 |
| TTM EPS See historical trend | 10.16(+3.67% YoY) |
| 52 Week High | 186.69 |
| 52 Week Low | 150.11 |
| TTM PE See historical trend | 14.94(Low PE) |
| Mkt. Cap ($ Billion) | 396.96 |
| Dividend Yield | 2.77 |
Advance Chart
*Delayed by 20 seconds.
MC Technicals
Moving Averages
| Days | |
|---|---|
| 5 | 151.99 |
| 10 | 152.85 |
| 20 | 152.99 |
| 50 | 159.17 |
| 100 | 167.55 |
| 200 | 168.54 |
Returns
Price Performance
| 1 Week | -1.34% | |
| 1 Month | -0.93% | |
| 3 Months | -14.10% | |
| YTD | -14.03% | |
| 1 Year | -14.62% | |
| 3 Years | 23.28% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| J&J | 151.85 | -0.95 | 396.96 | 14.94 | 10.16 | 2.77 | 186.69/150.11 | -0.93 | Very Bearish |
| Eli Lilly | 337.65 | 0.91 | 320.75 | 41.73 | 8.09 | 1.21 | 384.44/276.83 | 8.47 | Bullish |
| AbbVie | 158.25 | 0.45 | 279.84 | 11.38 | 13.90 | 4.20 | 175.91/134.09 | 2.82 | Very Bullish |
| Merck & Co | 105.53 | -1.31 | 267.51 | 14.11 | 7.48 | 3.20 | 115.49/80.74 | -0.69 | Bearish |
| Pfizer | 39.98 | -0.60 | 224.48 | 6.03 | 6.63 | 3.66 | 56.32/39.23 | -1.43 | Very Bearish |
Market news
- S&P 500 ends up slightly; SVB deal lifts bank sharesMarch 28, 2023 6:04 AM
- Transparency and disclosure key to addressing risks to global financial stability, says IMF reportMarch 27, 2023 11:37 AM
- More than 900 members of American Chamber of Commerce in China no longer regard China as a top-three investment priorityMarch 26, 2023 3:36 PM
- Following close to $100 billion in deposit withdrawals, Jerome Powell reassures US banking system is safeMarch 26, 2023 9:26 AM
About the company
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.